Citation

Bahr R, Lopez A, Rey JA. P T 2019; 44(6): 340-375.

Copyright

(Copyright © 2019, MediMedia)

DOI

unavailable

PMID

unavailable

Abstract

[Abstract unavailable]

Language: en

Keywords

adult; human; Suicide; female; male; ketamine; suicidal ideation; Suicidal ideation; randomized controlled trial; clinical trial; Ketamine; Treatment-resistant depression; fatigue; controlled study; antidepressant agent; clinical article; drug metabolism; protein binding; double blind procedure; hallucination; middle aged; drug mechanism; placebo; drug cost; drug efficacy; nausea; drug elimination; dizziness; euphoria; drug bioavailability; Montgomery Asberg Depression Rating Scale; Article; attention disturbance; phase 2 clinical trial; maximum plasma concentration; DSM-5; treatment resistant depression; esketamine; Esketamine